IOL Chemicals wins Chinese approval for a key heart-drug API
The clearance opens the world's largest bulk-drug market to one of the company's mainstay molecules. Subscribers can read the complete story.
The clearance opens the world's largest bulk-drug market to one of the company's mainstay molecules. Subscribers can read the complete story.
Request a free trial and our team will set up your access. Subscribers log in and return to this story in full.
Questions about access? Contact our team